In this week's episode, Blood podcast editor Laurie Sehn interviews Drs. Edward Cliff on his latest research published in volume 147 issue 14 of Blood. Dr. Cliff discusses "Global access to commercial CAR T-cell therapies: a cross-sectional study of health technology assessment across the G20 countries" which maps the mismatch between innovation and implementation across high-income and selected-upper-middle-income countries for US Food and Drug Administration–approved products and indications.
AI Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Blood Podcast
Effects of ZNF467 on HSPC fitness and Promotion of Follicular Lymphoma via DC-SIGN
Pathophysiology of ANKRD26-related thrombocytopenia and B-ALL recurrence after blinatumomab
Consequences of p53 loss and Gastrin for aGVHD of the Stomach
Review Series on Myeloproliferative Neoplasms
Get summaries like this every morning.
Free AI-powered recaps of Blood Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.